Medivir: Further Improvements with Fostrox - Redeye
Redeye comments on the slightly improved data, which are becoming mature, from the latest readout of the trial of fostrox in combination with Lenvima in liver cancer.
ANNONS
Redeye comments on the slightly improved data, which are becoming mature, from the latest readout of the trial of fostrox in combination with Lenvima in liver cancer.